HK Stock MarketDetailed Quotes

GRAND PHARMA (00512)

Watchlist
  • 6.220
  • +0.030+0.48%
Trading May 6 10:59 CST
22.08BMarket Cap17.77P/E (TTM)

GRAND PHARMA (00512) Revenue Breakdown Overview

By Business/Source

Currency:HKD
2025/FY
Stock NameRevenueRatio
生产及销售制药科技产品7.29B59.38%
生产及销售生物科技产品3.71B30.18%
生产及销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品1.28B10.44%

By Product

Currency:HKD
2025/FY
Stock NameRevenueRatio
生产及销售制药科技产品7.29B59.38%
生产及销售生物科技产品3.71B30.18%
生产及销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品1.28B10.44%

By Country/Region

Currency:HKD
2025/FY
Stock NameRevenueRatio
China10.63B86.51%
America759.42M6.18%
Europe432.68M3.52%
Asia (excl. China)408.91M3.33%
Other56.16M0.46%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More